Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-FAMOTIDINE | 40MG | TABLET | Resolved | 2019-09-26 | 2020-03-10 | 94880 |
ACT NABILONE | 0.5MG | CAPSULE | Resolved | 2019-12-19 | 2020-03-12 | 101740 |
ACT NABILONE | 1MG | CAPSULE | Resolved | 2019-12-19 | 2020-03-12 | 101730 |
ACT NABILONE | 1MG | CAPSULE | Resolved | 2019-10-17 | 2020-03-12 | 96733 |
ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2019-08-22 | 2020-03-12 | 92235 |
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2019-12-12 | 2020-03-12 | 101148 |
TEVA-ERLOTINIB | 100MG | TABLET | Resolved | 2020-01-30 | 2020-03-12 | 104896 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2020-02-13 | 2020-03-12 | 106008 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-02-21 | 2020-03-12 | 106948 |
TEVA-BROMAZEPAM | 6MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107952 |
TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2020-01-17 | 2020-03-12 | 103558 |
TEVA-TADALAFIL | 2.5MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107955 |
TEVA-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107961 |
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107989 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-09-12 | 2020-03-16 | 61368 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68626 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68632 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68629 |
TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2019-01-08 | 2020-03-19 | 71553 |
TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-01-30 | 2020-03-19 | 104902 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-PIOGLITAZONE | 15MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65026 |
TEVA-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65030 |
TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT ZOPICLONE | 5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65191 |
ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65213 |
ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65218 |
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |
ACT VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65298 |
ACT VENLAFAXINE XR | 150.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65305 |
ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81298 |